Michael J. Currens

4.7k total citations · 1 hit paper
26 papers, 3.9k citations indexed

About

Michael J. Currens is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Michael J. Currens has authored 26 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Virology, 14 papers in Infectious Diseases and 13 papers in Molecular Biology. Recurrent topics in Michael J. Currens's work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (14 papers) and Natural product bioactivities and synthesis (4 papers). Michael J. Currens is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (14 papers) and Natural product bioactivities and synthesis (4 papers). Michael J. Currens collaborates with scholars based in United States, Norway and Israel. Michael J. Currens's co-authors include Michael R. Boyd, Robert H. Shoemaker, Dominic A. Scudiero, Anne Monks, Sean Tierney, Kenneth D. Paull, James B. McMahon, Robert W. Buckheit, Kirk R. Gustafson and Robert J. Gulakowski and has published in prestigious journals such as Journal of Virology, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Michael J. Currens

26 papers receiving 3.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

1988 2.1k citations Dominic A. Scudiero, Robert H. Shoemaker et al. PubMed profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael J. Currens	1.7k	1.0k	694	641	503	26	3.9k
James R. Fuchs	2.7k 1.6×	1.3k 1.3×	1.0k 1.5×	980 1.5×	416 0.8×	112	5.6k
Hideki Nakashima	2.9k 1.7×	1.1k 1.1×	910 1.3×	1.2k 1.9×	390 0.8×	215	6.9k
John Kay	2.1k 1.2×	427 0.4×	1.3k 1.9×	1.2k 1.9×	87 0.2×	143	5.1k
Terry L. Bowlin	1.9k 1.1×	683 0.7×	843 1.2×	210 0.3×	394 0.8×	161	4.6k
Jim A. Turpin	1.4k 0.8×	730 0.7×	1.5k 2.2×	1.9k 2.9×	117 0.2×	91	4.3k
Li Su	1.2k 0.7×	287 0.3×	495 0.7×	579 0.9×	186 0.4×	210	3.5k
Tzu‐Ping Ko	4.4k 2.6×	596 0.6×	579 0.8×	106 0.2×	821 1.6×	217	7.3k
Richard L. Tolman	1.5k 0.9×	816 0.8×	478 0.7×	167 0.3×	221 0.4×	103	3.3k
Donatella Taramelli	1.4k 0.8×	1.3k 1.2×	594 0.9×	69 0.1×	272 0.5×	194	5.7k
Donald T. Dubin	3.8k 2.2×	269 0.3×	855 1.2×	413 0.6×	154 0.3×	81	5.5k

Countries citing papers authored by Michael J. Currens

Since Specialization

Citations

This map shows the geographic impact of Michael J. Currens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Currens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Currens more than expected).

Fields of papers citing papers by Michael J. Currens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Currens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Currens. The network helps show where Michael J. Currens may publish in the future.

Co-authorship network of co-authors of Michael J. Currens

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Currens. A scholar is included among the top collaborators of Michael J. Currens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Currens. Michael J. Currens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McCloud, Thomas G., et al.. (2012). Discovery and preliminary SAR of bisbenzylisoquinoline alkaloids as inducers of C/EBPα. Bioorganic & Medicinal Chemistry. 20(15). 4646–4652. 3 indexed citations

Gussio, Rick, Michael J. Currens, Dominic A. Scudiero, et al.. (2010). RSK2 Binding Models Delineate Key Features for Activity.. PubMed. 2(5). 587–598. 2 indexed citations

Dorjsuren, Dorjbal, Xulin Chen, Weimin Zhu, et al.. (2005). Chemical library screen for novel inhibitors of Kaposi's sarcoma-associated herpesvirus processive DNA synthesis. Antiviral Research. 69(1). 9–23. 31 indexed citations

Stephen, Andrew G., Karen M. Worthy, Eric M. Towler, et al.. (2002). Identification of HIV-1 nucleocapsid protein: nucleic acid antagonists with cellular anti-HIV activity. Biochemical and Biophysical Research Communications. 296(5). 1228–1237. 47 indexed citations

Shoemaker, Robert, Dominic A. Scudiero, Giovanni Melillo, et al.. (2002). Application of High-Throughput, Molecular-Targeted Screening to Anticancer Drug Discovery. Current Topics in Medicinal Chemistry. 2(3). 229–246. 69 indexed citations

O’Keefe, Barry R., Shilpa R. Shenoy, Dong Xie, et al.. (2000). Analysis of the Interaction between the HIV-Inactivating Protein Cyanovirin-N and Soluble Forms of the Envelope Glycoproteins gp120 and gp41. Molecular Pharmacology. 58(5). 982–992. 64 indexed citations

Boyd, Michael R., Kirk R. Gustafson, James B. McMahon, et al.. (1997). Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrobial Agents and Chemotherapy. 41(7). 1521–1530. 483 indexed citations

Currens, Michael J., Jennifer Mariner, James B. McMahon, & Michael R. Boyd. (1996). Kinetic analysis of inhibition of human immunodeficiency virus type-1 reverse transcriptase by calanolide A.. Journal of Pharmacology and Experimental Therapeutics. 279(2). 652–661. 40 indexed citations

10.

Currens, Michael J., Robert J. Gulakowski, Jennifer Mariner, et al.. (1996). Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1.. Journal of Pharmacology and Experimental Therapeutics. 279(2). 645–651. 50 indexed citations

11.

McMahon, James B., R W Buckheit, Robert J. Gulakowski, et al.. (1996). Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor.. Journal of Pharmacology and Experimental Therapeutics. 276(1). 298–305. 11 indexed citations

12.

Beutler, John A., Yoel Kashman, Mark Tischler, et al.. (1995). A Reinvestigation of Maprounea Triterpenes. Journal of Natural Products. 58(7). 1039–1046. 14 indexed citations

13.

Buckheit, R W, Valerie Fliakas-Boltz, Walter J. Decker, et al.. (1995). Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroups. Antiviral Research. 26(2). 117–132. 59 indexed citations

14.

McMahon, James B., Michael J. Currens, Robert J. Gulakowski, et al.. (1995). Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms. Antimicrobial Agents and Chemotherapy. 39(2). 484–488. 84 indexed citations

15.

Fuller, Richard W., Michael J. Currens, John H. Cardellina, & Michael R. Boyd. (1994). Bioactive Prenylated Hydroquinones from the SpongeSarcotragussp. Natural product letters. 5(3). 179–181. 1 indexed citations

16.

Kashman, Yoel, Kirk R. Gustafson, Ray W. Fuller, et al.. (1992). HIV inhibitory natural products. Part 7. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. Journal of Medicinal Chemistry. 35(15). 2735–2743. 465 indexed citations

17.

Perno, Carlo Federico, David A. Cooney, Michael J. Currens, et al.. (1990). Ability of Anti-HIV Agents to Inhibit HIV Replication in Monocyte/Macrophages or U937 Monocytoid Cells Under Conditions of Enhancement by GM-CSF or Anti-HIV Antibody. AIDS Research and Human Retroviruses. 6(8). 1051–1055. 22 indexed citations

18.

Ahluwalia, Gurpreet S., David A. Cooney, Michael J. Currens, et al.. (1990). Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the antiviral nucleoside 2′,3′-dideoxyguanosine. Biochemical and Biophysical Research Communications. 171(3). 1297–1303. 20 indexed citations

19.

Hayashi, Seiji, Robert L. Fine, Ting‐Chao Chou, et al.. (1990). In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitors. Antimicrobial Agents and Chemotherapy. 34(1). 82–88. 39 indexed citations

20.

Scudiero, Dominic A., Robert H. Shoemaker, Kenneth D. Paull, et al.. (1988). Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.. PubMed. 48(17). 4827–33. 2099 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact